Furuta R, Yamagishi J, Kotani H, Sakamoto F, Fukui T, Matsui Y, Sohmura Y, Yamada M, Yoshimura T, Larsen C G
Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Osaka.
J Biochem. 1989 Sep;106(3):436-41. doi: 10.1093/oxfordjournals.jbchem.a122870.
A putative mature human neutrophil chemotactic factor (NCF) corresponding to the C-terminal 72 amino acids of its precursor was directly produced in Escherichia coli by recombinant DNA technology. Human NCF was present in both the soluble and insoluble protein fractions of the homogenate of host cells, and it was partially purified as a water-soluble polypeptide from both fractions, separately. The partially purified NCF preparation was highly purified to an endotoxin-free homogeneous polypeptide by means of CM-Sepharose CL-6B column chromatography and gel filtration on Toyopearl HW-55. No difference between the human NCF preparations purified from both starting materials could be found concerning purity, primary structure, solubility, molecular weight, and chemotactic activity for human neutrophils. The amino acid sequence of recombinant human NCF was identical to the sequence deduced from the cDNA sequence. A methionine residue due to the translation initiation codon was removed. Recombinant human NCF was found to be biologically active and to exhibit chemotactic activity for human neutrophils in vitro and cause a neutrophil infiltration in vivo in mice.
利用重组DNA技术在大肠杆菌中直接产生了一种假定的成熟人中性粒细胞趋化因子(NCF),它对应于其前体的C末端72个氨基酸。人NCF存在于宿主细胞匀浆的可溶性和不溶性蛋白组分中,并且分别从这两个组分中作为水溶性多肽进行了部分纯化。通过CM - Sepharose CL - 6B柱色谱和Toyopearl HW - 55凝胶过滤,将部分纯化的NCF制剂高度纯化至无内毒素的均一多肽。从两种起始材料纯化得到的人NCF制剂在纯度、一级结构、溶解度、分子量和对人中性粒细胞的趋化活性方面均未发现差异。重组人NCF的氨基酸序列与从cDNA序列推导的序列相同。由于翻译起始密码子产生的甲硫氨酸残基被去除。发现重组人NCF具有生物活性,在体外对人中性粒细胞表现出趋化活性,并在小鼠体内引起中性粒细胞浸润。